Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Clin Chim Acta ; 493: 148-155, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-30858092

RESUMO

BACKGROUND: Cerebral Creatine deficiency syndromes (CCDS) include three hereditary diseases affecting the metabolism of creatine (Cr): arginine glycine amidinotransferase deficiency, guanidinoacetate methyltransferase deficiency and disorders of creatine transporter. These pathologies cause a brain creatine deficiency responsible of non-specific neurological impairments with mental retardation. LC-MS/MS measurements of guanidinoacetic acid (GAA) and creatine in urine and plasma are an important screening test to identify the deficit. Analysis of this polar and basic molecules not hold on standard column requires a derivatization step to butyl-esters. To overcome this long and fastidious derivatization, an ion pairing (IP) method was chosen in this study. METHOD: IP method was validated using Comité francais d'accréditation (COFRAC) recommendations. Then, urine GAA and creatine of 15 patients with a CDS deficiency suspected were tested y LC-MS/MS using IP technique, and performances were assessed with reference laboratory method (butylation method). Moreover, references values were suggested y the study of 100 urines samples of healthy patients. RESULTS: The method developed provided a good accuracy and precision with intra and inter-day coefficients of variation (CVs) <15%. The curve was linear for the biological and pathological concentrations. The comparison with the reference method did not reveal any significant difference for analytical performances but showed a simplification of the preparation of samples. CONCLUSION: The use of IP technique that we have developed demonstrated a good correlation with the butylation method. Moreover, this new method not only allows a simplification of the technique, but also decreases in run time.


Assuntos
Técnicas de Laboratório Clínico/métodos , Técnicas de Laboratório Clínico/normas , Creatina/urina , Glicina/análogos & derivados , Guanidinoacetato N-Metiltransferase/deficiência , Transtornos do Desenvolvimento da Linguagem/urina , Transtornos dos Movimentos/congênito , Cromatografia Líquida de Alta Pressão , Glicina/urina , Guanidinoacetato N-Metiltransferase/urina , Humanos , Transtornos do Desenvolvimento da Linguagem/diagnóstico , Transtornos dos Movimentos/diagnóstico , Transtornos dos Movimentos/urina , Espectrometria de Massas em Tandem
2.
Genet Med ; 19(2): 256-263, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-28055022

RESUMO

Disclaimer: These ACMG Standards and Guidelines are intended as an educational resource for clinical laboratory geneticists to help them provide quality clinical laboratory genetic services. Adherence to these standards and guidelines is voluntary and does not necessarily assure a successful medical outcome. These Standards and Guidelines should not be considered inclusive of all proper procedures and tests or exclusive of others that are reasonably directed to obtaining the same results. In determining the propriety of any specific procedure or test, clinical laboratory geneticists should apply their professional judgment to the specific circumstances presented by the patient or specimen. Clinical laboratory geneticists are encouraged to document in the patient's record the rationale for the use of a particular procedure or test, whether or not it is in conformance with these Standards and Guidelines. They also are advised to take notice of the date any particular guideline was adopted, and to consider other relevant medical and scientific information that becomes available after that date. It also would be prudent to consider whether intellectual property interests may restrict the performance of certain tests and other procedures.Cerebral creatine deficiency syndromes are neurometabolic conditions characterized by intellectual disability, seizures, speech delay, and behavioral abnormalities. Several laboratory methods are available for preliminary and confirmatory diagnosis of these conditions, including measurement of creatine and related metabolites in biofluids using liquid chromatography-tandem mass spectrometry or gas chromatography-mass spectrometry, enzyme activity assays in cultured cells, and DNA sequence analysis. These guidelines are intended to standardize these procedures to help optimize the diagnosis of creatine deficiency syndromes. While biochemical methods are emphasized, considerations for confirmatory molecular testing are also discussed, along with variables that influence test results and interpretation.Genet Med 19 2, 256-263.


Assuntos
Amidinotransferases/deficiência , Erros Inatos do Metabolismo dos Aminoácidos/genética , Encefalopatias Metabólicas Congênitas/genética , Creatina/deficiência , Creatina/metabolismo , Guanidinoacetato N-Metiltransferase/deficiência , Deficiência Intelectual/genética , Transtornos do Desenvolvimento da Linguagem/genética , Deficiência Intelectual Ligada ao Cromossomo X/genética , Transtornos dos Movimentos/congênito , Proteínas da Membrana Plasmática de Transporte de Neurotransmissores/deficiência , Proteínas Repressoras/genética , Distúrbios da Fala/genética , Amidinotransferases/sangue , Amidinotransferases/líquido cefalorraquidiano , Amidinotransferases/genética , Amidinotransferases/urina , Erros Inatos do Metabolismo dos Aminoácidos/sangue , Erros Inatos do Metabolismo dos Aminoácidos/líquido cefalorraquidiano , Erros Inatos do Metabolismo dos Aminoácidos/urina , Encefalopatias Metabólicas Congênitas/sangue , Encefalopatias Metabólicas Congênitas/líquido cefalorraquidiano , Encefalopatias Metabólicas Congênitas/urina , Técnicas de Laboratório Clínico/métodos , Creatina/sangue , Creatina/líquido cefalorraquidiano , Creatina/genética , Creatina/urina , Deficiências do Desenvolvimento/sangue , Deficiências do Desenvolvimento/líquido cefalorraquidiano , Deficiências do Desenvolvimento/genética , Deficiências do Desenvolvimento/urina , Testes Genéticos/normas , Genética Médica/normas , Genômica , Guanidinoacetato N-Metiltransferase/sangue , Guanidinoacetato N-Metiltransferase/líquido cefalorraquidiano , Guanidinoacetato N-Metiltransferase/genética , Guanidinoacetato N-Metiltransferase/urina , Guias como Assunto , Humanos , Deficiência Intelectual/sangue , Deficiência Intelectual/líquido cefalorraquidiano , Deficiência Intelectual/urina , Transtornos do Desenvolvimento da Linguagem/sangue , Transtornos do Desenvolvimento da Linguagem/líquido cefalorraquidiano , Transtornos do Desenvolvimento da Linguagem/urina , Deficiência Intelectual Ligada ao Cromossomo X/sangue , Deficiência Intelectual Ligada ao Cromossomo X/líquido cefalorraquidiano , Deficiência Intelectual Ligada ao Cromossomo X/urina , Transtornos dos Movimentos/sangue , Transtornos dos Movimentos/líquido cefalorraquidiano , Transtornos dos Movimentos/genética , Transtornos dos Movimentos/urina , Proteínas da Membrana Plasmática de Transporte de Neurotransmissores/sangue , Proteínas da Membrana Plasmática de Transporte de Neurotransmissores/líquido cefalorraquidiano , Proteínas da Membrana Plasmática de Transporte de Neurotransmissores/genética , Proteínas da Membrana Plasmática de Transporte de Neurotransmissores/urina , Proteínas Repressoras/sangue , Proteínas Repressoras/líquido cefalorraquidiano , Proteínas Repressoras/urina , Distúrbios da Fala/sangue , Distúrbios da Fala/líquido cefalorraquidiano
3.
Pract Neurol ; 17(3): 207-211, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28119378

RESUMO

Epilepsy commonly presents in childhood as part of a syndrome, and some such children may reach adult services without an underlying syndromic diagnosis. For adult neurologists taking over their care, it is often unclear how hard to search for an underlying diagnosis. The diagnostic yield may be small and such a diagnosis may not change management. Young adults with learning difficulties are also challenging to investigate, as they may not tolerate standard epilepsy tests.We present such a case in which simple tests identified a unifying diagnosis. With the new diagnosis came a new treatment that had a significant impact on seizures and quality of life.


Assuntos
Epilepsia/etiologia , Epilepsia/terapia , Guanidinoacetato N-Metiltransferase/deficiência , Transtornos do Desenvolvimento da Linguagem/complicações , Transtornos dos Movimentos/congênito , Adulto , Creatina/sangue , Creatina/uso terapêutico , Creatina/urina , Guanidinoacetato N-Metiltransferase/sangue , Guanidinoacetato N-Metiltransferase/genética , Guanidinoacetato N-Metiltransferase/metabolismo , Guanidinoacetato N-Metiltransferase/urina , Humanos , Transtornos do Desenvolvimento da Linguagem/genética , Transtornos do Desenvolvimento da Linguagem/metabolismo , Masculino , Transtornos dos Movimentos/complicações , Transtornos dos Movimentos/genética , Transtornos dos Movimentos/metabolismo , Mutação/genética
4.
Brain Dev ; 32(2): 79-81, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19289269

RESUMO

An increasing number of disorders of metabolism are becoming amenable to the treatment, and GAMT deficiency is one of them. The symptoms and signs are reviewed, emphasising that delayed language development is a particular feature. Other symptoms include learning disorders, autistic behaviour, epileptic seizures, and movement disorders. The condition is inherited in an autosomal recessive manner, and mutations in the GAMT gene severely affect the activity of guanidinoacetate. The MRI scan shows an increased signal in the globus pallidus, and the diagnosis is confirmed by finding increased guanidinoacetate in the urine and a low plasma creatine. Other methods of diagnosis are discussed. Treatment is based on giving creatine supplementation orally and a low-protein diet with restricted arginine and increased ornithine. This results in improvement of many of the symptoms, especially of the epileptic seizures and the abnormal movements. It is justifiable to consider this condition in any patient with unexplained learning disorders.


Assuntos
Erros Inatos do Metabolismo dos Aminoácidos/genética , Erros Inatos do Metabolismo dos Aminoácidos/fisiopatologia , Guanidinoacetato N-Metiltransferase/deficiência , Erros Inatos do Metabolismo dos Aminoácidos/complicações , Erros Inatos do Metabolismo dos Aminoácidos/dietoterapia , Arginina/metabolismo , Creatina/administração & dosagem , Diagnóstico Diferencial , Dieta com Restrição de Proteínas , Suplementos Nutricionais , Guanidinoacetato N-Metiltransferase/sangue , Guanidinoacetato N-Metiltransferase/genética , Guanidinoacetato N-Metiltransferase/urina , Humanos , Deficiências da Aprendizagem/etiologia , Deficiências da Aprendizagem/genética , Imageamento por Ressonância Magnética , Ornitina/administração & dosagem
5.
Med. clín (Ed. impr.) ; 133(19): 745-749, nov. 2009. tab, ilus
Artigo em Espanhol | IBECS | ID: ibc-83838

RESUMO

Fundamento y objetivo: Los síndromes de deficiencia cerebral de creatina (Cr) constituyen un grupo de enfermedades neurometabólicas caracterizadas por deficiencia o ausencia de Cr en el cerebro. Cursan con retraso del desarrollo/mental y trastornos del lenguaje, y puede asociarse a epilepsia o a trastornos del movimiento. Se conocen 3 defectos: 2 de la síntesis —deficiencia de guanidinoacetato metiltransferasa (GAMT) y argininaglicina amidinotransferasa (AGAT)— y uno del transporte (CRTR). En este trabajo presentamos los 3 primeros pacientes españoles con deficiencia de GAMT y comparamos su fenotipo clínico y respuesta al tratamiento con otros casos publicados. Pacientes y método: Los pacientes presentan retraso mental, epilepsia y conducta autista. La paciente 1 asocia corea grave. Pacientes y método: El diagnóstico se realizó mediante estudios bioquímicos para cuantificar metabolitos específicos y actividad enzimática y genéticos del gen GAMT. Resultados: En orina y plasma se detectó aumento de guanidinoacetato. La resonancia magnética con espectroscopia reveló reducción marcada de Cr cerebral. Los estudios enzimáticos mostraron disminución de la actividad GAMT en fibroblastos y el estudio molecular reveló mutaciones en el gen GAMT. Tras el diagnóstico, se inició tratamiento con suplemento de Cr, y se asoció en los pacientes 2 y 3 una dieta restringida en arginina y suplemento de ornitina, con mejoría parcial. Conclusiones: Los pacientes con deficiencia de GAMT presentan un fenotipo inespecífico pero relativamente constante. Deben buscarse los síndromes de deficiencia cerebral de Cr en pacientes con retraso mental/psicomotor de etiología desconocida, especialmente si se acompañan de trastornos del movimiento y epilepsia. Es importante el diagnóstico precoz en casos tratables como la deficiencia de GAMT (AU)


Background and objetive: Brain creatine (Cr) deficiencies are a group of inborn errors of metabolism that are characterized by an absence or severe reduction of brain Cr. Clinically, these patients can display psychomotor/mental retardation and language disorders, commonly associated with epilepsy or movement disorders. Three metabolic defects are known: two affect synthesis – guanidinoacetate metiltransferase (GAMT) and glycine amidinotransferase (AGAT) deficiencies– and one affect the Cr transporter (CRTR). We present the first three Spanish patients with GAMT deficiency, and we compare their clinical phenotype and treatment response with other published cases. Patients and method: The three patients presented mental retardation, epilepsy and autistic behaviour. Patient 1 also had severe chorea. Diagnosis was done by biochemical and genetic procedures (guanidinoacetate quantification, determination of GAMT activity and mutation analysis in the GAMT gene).Results: An increase of guanidinoacetate was detected in urine and plasma. Brain magnetic resonance spectroscopy revealed low Cr levels. Enzymatic studies revealed a decreased GAMT activity in fibroblasts. Molecular analysis detected pathogenic mutations in the GAMT gene. Results: After the deficiency was confirmed, the patients started treatment with Cr. In addition, patient 2 and 3 received an arginine-restricted diet and ornithine supplements. All them showed a partial improvement. Conclusions: Patients with GAMT deficiency have an unspecific but relatively constant clinical presentation. Brain Cr deficiency should be considered in patients with mental retardation of unknown aetiology, specially in those with movement disorders or epilepsy. Early diagnosis is important in cases with known treatment such as GAMT deficiency (AU)


Assuntos
Humanos , Masculino , Feminino , Criança , Adolescente , Pessoa de Meia-Idade , Creatina/deficiência , Encefalopatias Metabólicas/genética , Guanidinoacetato N-Metiltransferase/genética , Encefalopatias Metabólicas/diagnóstico , Encefalopatias Metabólicas/tratamento farmacológico , Guanidinoacetato N-Metiltransferase/sangue , Guanidinoacetato N-Metiltransferase/urina , Mutação
6.
Dev Med Child Neurol ; 51(5): 404-7, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19388150

RESUMO

Guanidinoacetate methyltransferase (GAMT) deficiency is a disorder of creatine biosynthesis, characterized by early-onset learning disability and epilepsy in most affected children. Severe expressive language delay is a constant feature even in the mildest clinical phenotypes.We report the clinical, biochemical, imaging, and treatment data of two female siblings (18y and 13y) with an unusual phenotype of GAMT deficiency. The oldest sibling had subacute onset of a movement disorder at age 17 years, later than has been previously reported. The younger sibling had better language skills than previously described in this disorder. After treatment with creatine, arginine restriction and ornithine-supplemented diet, seizure severity and movement disorder were reduced but cognition did not improve. This report confirms that GAMT deficiency, a heterogeneous, potentially treatable disorder, detected by increased levels of guanidinoacetate in body fluids (e.g. plasma or urine) or by an abnormal creatine peak on magnetic resonance spectroscopy, should be considered in patients of any age with unexplained, apparently static learning disability and epilepsy.


Assuntos
Encéfalo/patologia , Guanidinoacetato N-Metiltransferase/deficiência , Transtornos do Desenvolvimento da Linguagem/dietoterapia , Transtornos do Desenvolvimento da Linguagem/enzimologia , Deficiências da Aprendizagem/enzimologia , Transtornos dos Movimentos/dietoterapia , Transtornos dos Movimentos/enzimologia , Administração Oral , Adolescente , Idade de Início , Biomarcadores/sangue , Biomarcadores/urina , Creatina/uso terapêutico , Creatinina/sangue , Creatinina/urina , Feminino , Guanidinoacetato N-Metiltransferase/sangue , Guanidinoacetato N-Metiltransferase/urina , Humanos , Transtornos do Desenvolvimento da Linguagem/patologia , Deficiências da Aprendizagem/dietoterapia , Deficiências da Aprendizagem/patologia , Imageamento por Ressonância Magnética , Transtornos dos Movimentos/patologia , Ornitina/uso terapêutico , Índice de Gravidade de Doença , Resultado do Tratamento , Gêmeos Dizigóticos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...